N.J. Admin. Code § 8:43A-14.3

Current through Register Vol. 56, No. 23, December 2, 2024

Section 8:43A-14.3 - Infection prevention measures

(a) Infection prevention activities shall be based on the Centers for Disease Control and Prevention Guidelines, and Healthcare Infection Control Practices Advisory Committee (that is, HICPAC) recommendations listed below, incorporated herein by reference, as amended and supplemented;

1. Guideline for Prevention of Catheter-Associated Urinary Tract Infections (2009 );

2. Guideline for Prevention of Intravascular Device-Related Infections (Infection Control and Hospital Epidemiology 1996; 17:438-73 and American Journal of Infection Control 1996; 24:262-93);

3. Guidelines for Prevention of Surgical Site Infections (1999) (Infection Control and Hospital Epidemiology 1999; 20:247-278);

4. Guidelines for Preventing Health-Care-Associated Pneumonia, 2003: Recommendation of CDC and the Healthcare Infection Control Practices Advisory Committee, published in the Morbidity and Mortality Weekly Report at MMWR 2004; 53 (No. RR-3), published by the Coordinating Center for Health Information and Service, available at http://www.cdc.gov/mmwr/PDF/rr/rr5303.pdf and at http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5303a1.htm;

5. Guideline for Hand Hygiene in Health-Care Settings: Recommendation of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force, published in the Morbidity and Mortality Weekly Report at MMWR 2002; 51 (No. RR-16), published by the Coordinating Center for Health Information and Service, available at http://www.cdc.gov/mmwr/PDF/rr/rr5116.pdf and at http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5116a1.htm;

6. Guideline for Infection Control in Hospital Personnel (1998);

7. Guideline for Isolation Precautions in Hospitals (Infection Control and Hospital Epidemiology 1996; 17:53-80 and the American Journal of Infection Control 1996; 24:24-52);

8. Guidelines for Preventing the Transmission of Mycobacterium tuberculosis in Health Care Facilities (Morbidity and Mortality Weekly Report 1994; 43:11-22); and

9. HICPAC Recommendations for Preventing the Spread of Vancomycin Resistance (Infection Control and Hospital Epidemiology 1995; 16:105-113).

(b) The guidelines listed at (a) above are available at http://www.cdc.gov/infectioncontrol/guidelines, index.htmland from the National Technical Information Service (NTIS) , 5301 Shawnee Road, Alexandria, VA 22312, (800) 363-2068. The HICPAC Recommendations for Preventing the Spread of Vancomycin Resistance is available on the CDC website at http://www.cdc.gov/mmwr/preview/mmwrhtml/00039349.htm .CDC's Hospital Infections Program's Methicillin-resistant Staphylococcus Aureus: Facts for Healthcare Workers is available at: http://www.cdc.gov/mrsa/healthcare/index.html .

(c) The Department shall allow facilities to diverge from the guidelines and recommendations listed at (a) above, provided that there is a sound infection control rationale based upon scientific research or epidemiologic data for the diversion.

N.J. Admin. Code § 8:43A-14.3

Repeal and New Rule, R.2004 d.299, effective 8/2/2004.
See: 35 N.J.R. 2838(a), 36 N.J.R. 3529(a).
Section was "Infection prevention measures".
Amended by R.2008 d.24, effective 1/22/2008.
See: 39 N.J.R. 2309(a), 40 N.J.R. 702(a).
Rewrote the introductory paragraph of (a), (a)4 and (a)5; and added (c).
Notice of readoption with technical change, effective 1/3/2022.
See: 54 N.J.R. 60(a).